Skip to content
BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP

HST Global, Inc. HSTC

14 fiscal years on record · USD · FY2023 reported · SEC filings only
$0
$-146,210

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 0.00
Revenue, FY2023 · full 14-year series below
Revenue $ Net income $
FY2023 · Revenue 0.0 · Net income -146210.0
150000300000-100000-200000
201020132016201920222023
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2023 · dividends + net buybacks

Total assetsUSD 1,526.00
EquityUSD -592,067.00
CashUSD 1,526.00
Current ratio0.00×

Equity funds -38799% of total assets.

The 14-year record

14 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
HSTC, 14-year financial record
Metric 20232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.0◌◌◌◌◌◌◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B◌◌◌◌◌◌◌◌◌◌◌◌−0.0−0.0
Income tax $B0.00.00.00.00.00.00.0◌◌◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.00.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $◌◌−0.03−0.040.13−0.070.000.00−0.01−0.01−0.01−0.01−0.01−0.03
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend——————————————
ROE % — not applicable: negative equity——————————————
Shares out B0.010.010.010.010.000.040.04◌◌◌◌◌◌◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 53 reconciliationsAUDITED

Reconciled in 14 of the 14 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inNevada
Fiscal year endsDecember 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2010

Share this section

Download image